Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for Croatia
Autor: | Nataša Jokić-Begić, Cecilija Rotim, Miroslav Samaržija, Latinka Basara, Alice Heaney, Stephen P. McKenna, Gzim Redžepi, Andrea Vukić Dugac, Marko Jakopović, Ana Hećimović, Sanja Popović-Grle |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Quality of life
Reproducibility of results Adult Male 030213 general clinical medicine 0209 industrial biotechnology Croatia Hypertension Pulmonary 02 engineering and technology Severity of Illness Index 03 medical and health sciences 020901 industrial engineering & automation 0302 clinical medicine Surveys and Questionnaires Activities of Daily Living Outcome Assessment Health Care Humans Medicine Cambridge Pulmonary Hypertension Outcome Review Original Scientific Papers Reliability (statistics) Aged business.industry Debriefing Construct validity Cognition General Medicine Middle Aged Translating Adaptation Physiological humanities Clinical research Scale (social sciences) Female business Clinical psychology hypertension pulmonary quality of life reproducibility of results surveys and questionnaires |
Zdroj: | Acta Clinica Croatica |
Popis: | SUMMARY Pulmonary hypertension (PH) is a chronic disease which severely impairs quality of life (QoL). The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is the first disease-specific tool to assess patient-reported symptoms, functioning and QoL in PH patients. The aim of this study was to adapt and validate the CAMPHOR for use in Croatia. The adaptation process involved three stages: translation (bilingual and lay panel), cognitive debriefing interviews with patients and psychometric validation. For the latter stage, a postal survey was conducted with 50 patients to examine the reliability and validity of the adapted scale. All three scales of the Croatian CAMPHOR demonstrated excellent internal consistency (Symptoms = 0.93; Activity limitations = 0.94; QoL = 0.92) and test-retest reliability correlations (Symptoms = 0.90; Activity limitations = 0.95; QoL = 0.90). Predicted correlations with the SF-36 scales provided evidence for construct validity of the CAMPHOR scales. Evidence for known group validity was shown by the ability of the scales to distinguish between participants based on patient-perceived general health and disease severity. The Croatian version of the CAMPHOR is a valid and reliable tool for use in clinical routine and clinical research. |
Databáze: | OpenAIRE |
Externí odkaz: |